Who
Scott Koenig
Director
Company insider
Files Form 4 as: President and CEO, MacroGenics; Director, Crescent Biopharma; Director, Applied Genetic Technologies.
In numbers
- Trades disclosed
- 97
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 9 Oct 2013
- Last trade
- 19 May 2026
- Last filed
- 20 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 15 Feb 2026filed 17 Feb 2026 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —21,165 at $0.00 | filing |
| 15 Feb 2026filed 17 Feb 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,165 at $0.00 | filing |
| 15 Feb 2026filed 17 Feb 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,165 at $0.00 | filing |
| 15 Feb 2026filed 17 Feb 2026 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —21,165 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —15,831 | filing |
| 8 Feb 2026filed 10 Feb 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,831 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,831 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —15,831 | filing |
| 13 Aug 2025filed 15 Aug 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,165 at $0.00 | filing |
| 13 Aug 2025filed 15 Aug 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,664 at $0.00 | filing |
| 13 Aug 2025filed 15 Aug 2025 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —21,165 at $0.00 | filing |
| 13 Aug 2025filed 15 Aug 2025 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —31,664 at $0.00 | filing |
| 15 Feb 2025filed 19 Feb 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —42,329 at $0.00 | filing |
| 15 Feb 2025filed 19 Feb 2025 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code M | —42,329 at $0.00 | filing |
| 8 Feb 2025filed 11 Feb 2025 | MGNX MacroGenicsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,673 at $0.00 | filing |
| 8 Feb 2025filed 11 Feb 2025 | MGNX MacroGenicsBiotechnology | SEC FORM 4 Code A | —31,673 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.